FDA
-
-
-
-
-
-
-
JUVÉDERM® Day Returns to U.S. on August 19
-
-
-
-
-
-
-
SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development
-
-
-
-
-
-
-
EU panel backs AbbVie's Rinvoq for vitiligo treatment
-
-
-
-
-
-
-
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
-
-
-
-
-
-
-
FDA approves AbbVie's pivekimab sunirine-PVZY for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare hematologic malignancy
-
-
-
-
-
-
-
AbbVie submits FDA application for SKYRIZI subcutaneous dosing
-
-
-
-
-
-
-
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
-
328,876 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

